APLLTD

Alembic Pharmaceuticals Share Price Alembic Pharmaceuticals

₹984.8
0.05 (0.01%)
29 March, 2024 00:24 BSE: 533573 NSE: APLLTDISIN: INE901L01018

Start SIP in Alembic Pharmaceuticals

Start SIP

Alembic Pharmaceuticals Performance

Day Range

  • Low 970
  • High 997
₹ 984

52 Week Range

  • Low 462
  • High 1,094
₹ 984
  • Open Price994
  • Previous Close985
  • Volume141639

Alembic Pharmaceuticals Share Price

  • Over 1 Month -4.27%
  • Over 3 Month 30.39%
  • Over 6 Month 29.09%
  • Over 1 Year 105.79%

Alembic Pharmaceuticals Key Statistics

P/E Ratio 32.8
PEG Ratio 0.2
Market Cap Cr 19,358
Price to Book Ratio 4.4
EPS 17.6
Dividend 0.8
Relative Strength Index 52.07
Money Flow Index 49.19
MACD Signal -5.39
Average True Range 36.53
Alembic Pharmaceuticals Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,5881,4791,3321,307
Operating Expenses Qtr Cr 1,2511,2711,1671,138
Operating Profit Qtr Cr 337207166169
Depreciation Qtr Cr 69676674
Interest Qtr Cr 15151414
Tax Qtr Cr 2300-47
Net Profit Qtr Cr 23313498131
IndicatorMar 2023
Total Revenue Annual Cr 5,153
Operating Expenses Annual Cr 4,485
Operating Profit Annual in Cr 664
Depreciation Cr 273
Interest Annual Cr 49
Tax Annual Cr -1
Net Profit Annual Cr 347
IndicatorMar 2023
Cash from Operating Activity Annual Cr 730
Cash from Investing Activity Annual Cr -461
Cash from Financing Annual Activity Cr -261
Net Cash Flow Annual Cr 8
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 4,414
Fixed Assets Annual Cr 2,979
Total Non Current Assets Annual Cr 3,350
Total Current Assets Annual Cr 2,780
Total Assets Annual Cr 6,130
IndicatorMar 2023
Book Value Per Share Annual Rs 225
ROE Annual % 8
ROCE Annual % 9
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 13
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,6311,5951,4861,406
Operating Expenses Qtr Cr 1,3641,3871,2871,194
Operating Profit Qtr Cr 266208199212
Depreciation Qtr Cr 69686674
Interest Qtr Cr 15161414
Tax Qtr Cr 4-29-36
Net Profit Qtr Cr 180137121153
IndicatorMar 2023
Total Revenue Annual Cr 5,655
Operating Expenses Annual Cr 4,944
Operating Profit Annual in Cr 708
Depreciation Cr 275
Interest Annual Cr 50
Tax Annual Cr 13
Net Profit Annual Cr 342
IndicatorMar 2023
Cash from Operating Activity Annual Cr 724
Cash from Investing Activity Annual Cr -448
Cash from Financing Annual Activity Cr -262
Net Cash Flow Annual Cr 14
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 4,370
Fixed Assets Annual Cr 3,000
Total Non Current Assets Annual Cr 3,273
Total Current Assets Annual Cr 2,910
Total Assets Annual Cr 6,183
IndicatorMar 2023
Book Value Per Share Annual Rs 222
ROE Annual % 8
ROCE Annual % 10
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 13

Alembic Pharmaceuticals Technicals

EMA & SMA

Current Price
₹984.8
0.05 (0.01%)
pointer
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • ₹975.60
  • 50 Day
  • ₹957.39
  • 100 Day
  • ₹901.98
  • 200 Day
  • ₹823.29
  • 20 Day
  • ₹980.46
  • 50 Day
  • ₹983.04
  • 100 Day
  • ₹876.50
  • 200 Day
  • ₹803.21

Alembic Pharmaceuticals Resistance and Support

PIVOT
₹983.92
Resistance
First Resistance 998.23
Second Resistance 1,011.67
Third Resistance 1,025.98
RSI 52.07
MFI 49.19
MACD Single Line -5.39
MACD -5.42
Support
First Resistance 970.48
Second Resistance 956.17
Third Resistance 942.73

Alembic Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 146,293 8,113,410 55.46
Week 100,952 5,752,216 56.98
1 Month 122,759 6,862,241 55.9
6 Month 307,650 12,247,563 39.81

Alembic Pharmaceuticals Result Highlights

Alembic Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Alembic Pharmaceutic is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 5149.00 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2023. Alembic Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123.
Market Cap 19,398
Sales 5,707
Shares in Float 5.90
No of funds 179
Yield 0.81
Book Value 4.39
U/D Vol ratio 2.3
LTDebt / Equity
Alpha 0.15
Beta 1.13

Alembic Pharmaceuticals

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 69.61%69.61%69.61%69.61%
Mutual Funds 7.71%7.33%6.64%6.47%
Insurance Companies 6.52%6.57%6.74%6.55%
Foreign Portfolio Investors 4.52%4.51%4.34%4.55%
Financial Institutions/ Banks 0.03%0.03%0.03%0.04%
Individual Investors 8%8.24%8.98%9.08%
Others 3.61%3.71%3.66%3.7%

Alembic Pharmaceuticals Management

Name Designation
Mr. Chirayu Amin Chairman & CEO
Mr. Pranav Amin Managing Director
Mr. Shaunak Amin Managing Director
Mr. R K Baheti Director - Finance & CFO
Mr. K G Ramanathan Independent Director
Mr. Pranav Parikh Independent Director
Mr. Paresh Saraiya Independent Director
Dr. Archana Hingorani Independent Director
Mr. Ashok Barat Independent Director
Mr. Jai Diwanji Independent Director

Alembic Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Alembic Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-02-05 Quarterly Results
2023-11-07 Quarterly Results
2023-08-04 Quarterly Results
2023-05-05 Audited Results & Final Dividend
2023-02-01 Quarterly Results
Date Purpose Remarks
2023-07-28 FINAL Rs.8.00 per share(400%)Final Dividend
2022-08-18 INTERIM Rs.10.00 per share(500%)Dividend (Changed Final Dividend as Interim Divided)

Alembic Pharmaceuticals FAQs

What is Share Price of Alembic Pharmaceuticals ?

Alembic Pharmaceuticals share price is ₹984 As on 29 March, 2024 | 00:10

What is the Market Cap of Alembic Pharmaceuticals ?

The Market Cap of Alembic Pharmaceuticals is ₹19357.5 Cr As on 29 March, 2024 | 00:10

What is the P/E ratio of Alembic Pharmaceuticals ?

The P/E ratio of Alembic Pharmaceuticals is 32.8 As on 29 March, 2024 | 00:10

What is the PB ratio of Alembic Pharmaceuticals ?

The PB ratio of Alembic Pharmaceuticals is 4.4 As on 29 March, 2024 | 00:10

Q2FY23